Covid vaccine, a trip to the scientific heart of Spallanzani. Director Ippolito: “Italy is competitive despite few investments”

11/23/2020 Italy, World



[ad_1]

The Second wave from COVID-19-19? A consequence of the “gradual relaxation” of the summer months, when “we could not perceive that what happened in the northwest of the country could also happen in other areas.” Thus, Italy, after the first emergency shutdown last March and the reboot, he returned in the “darkest darkness” ofCoronavirus emergency. To say Giuseppe Ippolito, the scientific director of Spallanzani, the National Institute of Infectious Diseases of Rome (Inmi), one of the centers symbol of Italian research. Here the experimentation of GRAd-CoV2, the candidate vaccine against Covid from Reithera, the biotech company from Castel Romano, near Rome. A project, that of creating a “all italian vaccine“, For which eight million euros have been allocated, five million from the Lazio Region and three million from the Ministry of University and Scientific Research. And that, Ippolito himself clarifies, has “Italian inventors, is produced and tested in Italy and is funded by Italy”, is going to “compete in a world where funding for vaccine research has been enormous.”

I times? “The experimentation is progressingAt the end of November, the last patient in the elderly group will be registered. So, based on the promising results, this will allow us to present the documents to the regulatory agencies, to start the next phases “, specifies the scientific director of Inmi. “We hope that from the second half of December Reithera can submit an application for the compound to be evaluated by the EMA”, is the stated objective.

A challenge, that of pursuing a vaccine, also possible thanks to “Gym for AIDS“Which made it possible to develop antiviral drugs and tests. “Today as then they were necessary behavioral measures, just as there was and is a need for clear messages ”. For some time the population “did not face distancing measures”, because “it was necessary to return to the great fear of postwar syphilis, for personal protection, such as condoms. Or, for those with respiratory infection, the “great fear of tuberculosis.” In practice, Ippolito explains, “we had forgotten all this”. However, the lesson was not enough to avoid returning in full emergency, waiting for one or more vaccines to slow the number of the pandemic.



[ad_2]

Designed by Tricksfast Solutions
© Copyright 2025, All Rights Reserved